SCHEMBL6839360

SCHEMBL6839360

COc1ccc(CNCc2ccccc2)c2cc(C(=O)Nc3ccccc3)oc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.47
PDE4B Q07343 3/20 0.47
PDE4C Q08493 3/20 0.47
PDE4D Q08499 3/20 0.47
MAPT P10636 3/20 0.46
MAPK1 P28482 2/20 0.46
HTT P42858 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
NPY1R P25929 1/20 0.44
NPY2R P49146 1/20 0.44
ALOX5 P09917 1/20 0.43
ACHE P22303 1/20 0.43
BACE1 P56817 1/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838150 0.92 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL6836454 0.91 HTT (0.46) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL6837546 0.90 KMT2A (0.48) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL6833260 0.89 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL6837691 0.89 HTT (0.53) MAPK1HTTNPSR1LMNAPOLB
SCHEMBL6837974 0.89 NPC1 (0.45) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL6839400 0.88 PDE4A (0.45) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL6837853 0.86 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL6837902 0.85 NPC1 (0.52) MAPTLMNAPOLBKMT2AMEN1
SCHEMBL6837814 0.85 MEN1 (0.49) MAPTMAPK1HTTNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 PDE4A 4879/4885PDE4B 4877/4885PDE4C 4882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.